BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 3490534)

  • 1. Cyclosporine-induced autoimmunity. Conditions for expressing disease, requirement for intact thymus, and potency estimates of autoimmune lymphocytes in drug-treated rats.
    Sorokin R; Kimura H; Schroder K; Wilson DH; Wilson DB
    J Exp Med; 1986 Nov; 164(5):1615-25. PubMed ID: 3490534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclosporine-induced autoimmunity in rats carrying thymus allografts.
    Babcock SK; Niswender K; Wilson DB; Bellgrau D
    Transplantation; 1990 Aug; 50(2):278-81. PubMed ID: 2382294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effector mechanisms in cyclosporine A-induced syngeneic graft-versus-host disease. Role of CD4+ and CD8+ T lymphocyte subsets.
    Hess AD; Fischer AC; Beschorner WE
    J Immunol; 1990 Jul; 145(2):526-33. PubMed ID: 1973185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclosporin-induced autoimmunity: a role for marrow-derived cells presenting self antigens in the thymus.
    Babcock SK; Georgiu H; Kotzin B; Bellgau D
    Transplant Proc; 1989 Feb; 21(1 Pt 1):220-1. PubMed ID: 2650108
    [No Abstract]   [Full Text] [Related]  

  • 5. On the localization of effector cells in cyclosporin-induced autoimmunity.
    Wodzig KW; Majoor GD; van Breda Vriesman PJ
    Autoimmunity; 1991; 10(4):275-83. PubMed ID: 1772963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoimmune-mediated vasculopathy.
    Chen W; Thoburn CJ; Miura Y; Sommer M; Hruban R; Qian Z; Baldwin W; Hess AD
    Clin Immunol; 2001 Jul; 100(1):57-70. PubMed ID: 11414746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the pathogenic autoreactive T cells in cyclosporine-induced syngeneic graft-versus-host disease.
    Chen W; Thoburn C; Hess AD
    J Immunol; 1998 Dec; 161(12):7040-6. PubMed ID: 9862741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Host resistance to cyclosporine induced syngeneic graft-versus-host disease. Requirement for two distinct lymphocyte subsets.
    Fischer AC; Laulis MK; Horwitz L; Beschorner WE; Hess A
    J Immunol; 1989 Aug; 143(3):827-32. PubMed ID: 2526175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transfer of cyclosporine-associated syngeneic graft-versus-host disease by thymocytes. Resemblance to chronic graft-versus-host disease.
    Beschorner WE; Hess AD; Shinn CA; Santos GW
    Transplantation; 1988 Jan; 45(1):209-15. PubMed ID: 3257308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of syngeneic graft-versus-host disease by recovery of thymic microenvironment after cyclosporine.
    Beschorner WE; Ren H; Phillips J; Pulido HB; Hruban RH; Hess AD
    Transplantation; 1991 Oct; 52(4):668-74. PubMed ID: 1926347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclosporin A-induced autoimmune disease in mice.
    Bucy RP; Xu XY; Li J; Huang G
    J Immunol; 1993 Jul; 151(2):1039-50. PubMed ID: 8335890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of cyclosporine-induced syngeneic graft-versus-host disease in bone marrow transplantation by UV-B irradiated bone marrow cells.
    Ohajekwe OA; James T; Hardy MA; Oluwole SF
    Bone Marrow Transplant; 1995 Apr; 15(4):627-32. PubMed ID: 7655391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Requirements for the induction and adoptive transfer of cyclosporine-induced syngeneic graft-versus-host disease.
    Fischer AC; Beschorner WE; Hess AD
    J Exp Med; 1989 Mar; 169(3):1031-41. PubMed ID: 2647891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclosporin A-induced autologous graft-versus-host disease: a prototypical model of autoimmunity and active (dominant) tolerance coordinately induced by recent thymic emigrants.
    Wu DY; Goldschneider I
    J Immunol; 1999 Jun; 162(11):6926-33. PubMed ID: 10352315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Syngeneic graft-versus-host disease after allogeneic bone marrow transplantation and cyclosporine treatment.
    Hess AD; Vogelsang GB; Silanskis M; Friedman KA; Beschorner WE; Santos GW
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):487-92. PubMed ID: 3291285
    [No Abstract]   [Full Text] [Related]  

  • 16. Cyclosporine and the thymus: influence of irradiation and age on thymic immunopathology and recovery.
    Beschorner WE; Di Gennaro KA; Hess AD; Santos GW
    Cell Immunol; 1987 Dec; 110(2):350-64. PubMed ID: 3500795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Susceptibility to cyclosporin A-induced autoimmunity: strain differences in relation to autoregulatory T cells.
    Barendrecht MM; Tervaert JW; van Breda Vriesman PJ; Damoiseaux JG
    J Autoimmun; 2002 Feb; 18(1):39-48. PubMed ID: 11869045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Susceptibility and resistance to cyclosporin A-induced autoimmunity in rats.
    Wodzig KW; Majoor GD; Van Breda Vriesman PJ
    Autoimmunity; 1993; 16(1):29-37. PubMed ID: 8136464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. X-irradiation of the thymus is not required for the induction of cyclosporine-induced autoimmunity.
    Beijleveld LJ; Damoiseaux JG; Wodzig KW; Van Breda Vriesman PJ
    Transplantation; 1995 Jun; 59(11):1601-5. PubMed ID: 7778176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T-cell maturation and clonal deletion in cyclosporine-induced autoimmunity.
    Prud'homme GJ; Sanders R; Parfrey NA; Ste-Croix H
    J Autoimmun; 1991 Apr; 4(2):357-68. PubMed ID: 1652970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.